This past November 19th MXBBB issued a recall for UMARY Hyaluronic Acid Tablets (30 Caplets, 850 MG) Why? Well, there were some unexpected guests called diclofenac and omeprazole. According to the FDA, consumers, distributors and retailers that have Umary on their hands should stop using it and return to the place of purchase for a full refund. Want to know more about this? Keep reading to get the full scoop on this voluntary recall, the risks involved, and what to do if you have the product.
What happened?
MXBBB is recalling one lot of UMARY Hyaluronic Acid Tablets after an FDA lab analysis confirmed that the product contains two undisclosed ingredients: diclofenac and omeprazole. The FDA conducted laboratory testing and found that the product, labeled as a dietary supplement for joint and skin health, was contaminated with prescription drugs. The product was distributed nationwide via Amazon.
What caused the issue?
An FDA lab analysis confirmed that the product contains two undisclosed ingredients: diclofenac and omeprazole. Both diclofenac (a commonly used NSAID, non-steroidal anti-inflammatory drug ) and omeprazole (a PPI, proton pump inhibitor) were not declared on the label. Here’s why that matters: Diclofenac, is an NSAID that can increase the risk of heart attack, stroke, bleeding, ulcers, and perforations in the stomach and intestines. People with certain pre-existing conditions (like heart disease or gastrointestinal disorders) are at higher risk. Omeprazole on the other hand it’s a PPI used for stomach acid problems, but it can mask severe stomach conditions like ulcers, erosions, or even cancer. It can also cause abdominal pain, diarrhea, and headaches in some people. Among the massive health issues this could cause, you can find heart issues, gastrointestinal damage (bleeding, ulcers, perforations), adverse drug interactions with other medications, especially NSAIDs, and the potential to mask stomach issues such as ulcers and cancers. This can affect people with existing heart or gastrointestinal conditions, those already taking other NSAIDs or PPIs. No confirmed adverse events have been reported yet, but it’s always better to be safe than sorry.
Brand | Product | Size | UPC Code | Lot Number | Best by Date | Issue |
Ummary | Acid Hyaluronic Caplets | 30 caplets 850g | 7502265120323 | 24183 | 07/01/24 | Undisclosed omeprazole and diclofenac |
Here’s what you should do
If you have purchased this product, take action! Here’s how:
- Check the label:
UPC Codes: 7502265120323
Best by dates: 07/01/24 - Identify the product:
UMARY ACID HYALURONIC, 30 CAPLETS 850 MG - What to do with the product:
MXBBB is notifying its distributors and customers by Amazon and is arranging for the return of all recalled products. Consumers/distributors/retailers that have Umary should stop using/return to the place of purchase for a full refund. Consumers should also contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. - Contact info:
Consumers with questions regarding this recall can contact MXBBB at (915)259-6936 or [email protected] 24/7. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. They should complete and submit the report Online through regular Mail or Fax: Download the form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
Ensuring a safe life
Recalls like this serve as a reminder of the importance of product transparency. Consumers rely on brands to provide accurate and safe information about what they’re consuming, and mistakes like these can have serious consequences. The industry must adopt stronger oversight and more rigorous quality control processes to ensure consumer safety. For companies like MXBBB, taking swift action is key to regaining customer trust and avoiding long-term reputational damage. While this may be a simple mislabeling issue, it’s a valuable lesson in vigilance and accountability.
Wanna know more about recalls like these? Contact our team!
